Overview

Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections

Status:
Unknown status

Trial end date:
2019-01-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to investigate if treatment with fecal microbiota transplantation or rectal bacteriotherapy is superior to standard vancomycin in patients with recurrent Clostridium Difficile infections.

Phase:

Phase 3

Details

Lead Sponsor:

Hvidovre University Hospital

Treatments:

Vancomycin